Literature DB >> 11813615

Evaluation of hemostatic changes and blood antioxidant capacity in acute and chronic pancreatitis.

L Kerekes1, P Arkossy, I Altorjay, M Huszka, J Kappelmayer, P Tóth, Z Szentkereszty, P Sápy.   

Abstract

BACKGROUND/AIMS: We examined changes in hemostasis, in levels of total antioxidant capacity, and pancreatic enzymes (amylase, lipase) in patients with pancreatitis 1, 3 and 7 days after admission to the clinic, in order to evaluate the inflammatory processes in acute and chronic pancreatitis and to identify new prognostic markers.
METHODOLOGY: The rate of CD62 expression--a marker of platelet hyperactivity--and the rate of platelet-leukocyte aggregates were measured by flow cytometry. The connection between the parameters measured and the severity of pancreatitis and also the differences of the parameters in acute and chronic pancreatitis were investigated.
RESULTS: On the basis of previous studies it was assumed, that there is a connection between the level of parameters measured and the inflammatory process in the pancreas, and also between the defending processes of the body against free radicals.
CONCLUSIONS: Based on our results, we suggest to extend the laboratory measurements to the investigation of hemostatic parameters. The measurement of plasma level of fibrinogen, von Willebrand factor and the rate of platelet activation is especially important.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11813615

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Mean platelet volume in patients with biliary and non-biliary acute pancreatitis.

Authors:  Yildiz Okuturlar; Aliye Soylu; Halil Dogan; Serdal Cakmak; Irem Kirac Utku; Bugra Oztosun; Cevher Akarsu; Sibel Ocak Serin; Akkan Avci; Osman Kones; Dogac N Ozucelik; Deniz Guzey; Ozlem Harmankaya; Abdulbaki Kumbasar
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis.

Authors:  Philipp A Reuken; Jonathan F Brozat; Alexander Koch; Tony Bruns; Stefanie Quickert; Oluwatomi Ibidapo-Obe; Johanna Reißing; Anika Franz; Sven Stengel; Ulf K-M Teichgräber; Michael Kiehntopf; Christian Trautwein; Andreas Stallmach
Journal:  J Intensive Care       Date:  2022-06-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.